Dilriva Inhalation Capsule 18 mcg contains Tiotropium 18 mcg, a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Tiotropium works by relaxing airway smooth muscles and reducing bronchoconstriction, providing sustained bronchodilation and improved airflow in patients with COPD.

COPD is a progressive lung disorder characterized by airflow limitation, chronic inflammation, and recurrent exacerbations, leading to symptoms such as shortness of breath, wheezing, persistent cough, and reduced exercise tolerance. Dilriva Inhalation Capsule delivers medication directly to the lungs via inhalation, ensuring rapid action and long-lasting relief while minimizing systemic side effects.

This once-daily inhalation therapy is designed to enhance lung function, control symptoms, and improve quality of life, making it an essential component of COPD management, especially in patients with moderate to severe disease.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Dilriva Inhalation Capsule 18 mcg is indicated for:

• Maintenance treatment of moderate to severe COPD

• Relief of dyspnea (shortness of breath)

• Improvement of lung function and exercise tolerance

• Prevention of COPD exacerbations

• Symptomatic management in patients with chronic bronchitis or emphysema

Key Benefits

• Provides long-acting bronchodilation for 24 hours

• Reduces airway constriction, breathlessness, and wheezing

• Improves lung function, exercise capacity, and daily activity

• Convenient once-daily inhalation for better adherence

• Direct lung delivery ensures rapid onset and reduced systemic side effects

Mechanism of Action

Tiotropium is a selective long-acting muscarinic M3 receptor antagonist. Muscarinic M3 receptors in airway smooth muscles mediate bronchoconstriction when stimulated by acetylcholine. By blocking these receptors, Tiotropium relaxes airway muscles, prevents narrowing of the airways, and reduces mucus secretion. This leads to improved airflow, decreased dyspnea, and enhanced exercise tolerance in patients with COPD.

Dosage and Administration

• The recommended dose is one inhalation capsule (18 mcg) once daily using a compatible dry powder inhaler (DPI).

• Do not swallow the capsule; it must be inhaled using the prescribed inhaler device.

• Take at the same time each day to maintain consistent therapeutic effect.

• Do not exceed the recommended dose.

Precautions

• Not intended for acute bronchospasm or asthma attacks; only for maintenance therapy.

• Use cautiously in patients with glaucoma, urinary retention, or severe cardiovascular disease.

• Inform your healthcare provider about all medications being taken to prevent potential interactions.

• Seek immediate medical attention if severe palpitations, chest pain, or breathing difficulties occur.

• Not recommended for pediatric patients unless prescribed by a physician.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Dilriva Inhalation Capsule 18 mcg is generally well tolerated. Possible side effects may include:

• Dry mouth

• Throat irritation or cough

• Headache

• Rarely, palpitations or blurred vision

• Mild dizziness

Most side effects are mild, transient, and often resolve with continued use. Dose adjustments can help minimize adverse effects.

Storage

Store below 30°C in a cool, dry place, away from direct sunlight and moisture. Keep capsules out of reach of children.